The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Demyanov I.A.

SBEI HPE KSMU of the Ministry of Healthcare of Russia, Department of Psychiatry, Krasnodar, Russia;
State Budgetary Healthcare Institution 'Specialized Clinical Psychiatric Hospital #1', Krasnodar, Russia

Boĭko E.O.

GBOU VPO "Kubanskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava Rossii, Krasnodar, 350063, Rossiĭskaia Federatsiia

Zaĭtseva O.G.

GBOU VPO "Kubanskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava Rossii, Krasnodar, 350063, Rossiĭskaia Federatsiia

Pogodina M.G.

SBEI HPE KSMU of the Ministry of Healthcare of Russia, Psychiatry Department of Post-Graduate Education, Krasnodar, Russia;
State Budgetary Healthcare Institution 'Specialized Clinical Psychiatric Hospital #1', Krasnodar, Russia

The efficacy of alimemazine (solution for intramuscular injection) in complex with antidepressants in the treatment of anxiety and depressive disorders

Authors:

Demyanov I.A., Boĭko E.O., Zaĭtseva O.G., Pogodina M.G.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(8): 32‑37

DOI: 10.17116/jnevro201911908132

Views: 5358

Downloaded: 150

Download PDF (RU)
Contact the author
Table of contents

THE EFFICACY OF ALIMEMAZINE (SOLUTION FOR INTRAMUSCULAR INJECTION) IN COMPLEX WITH ANTIDEPRESSANTS IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS
THE EFFICACY OF ALIMEMAZINE (SOLUTION FOR INTRAMUSCULAR INJECTION) IN COMPLEX WITH ANTIDEPRESSANTS IN THE TREATMENT OF ANXIETY AND DEPRESSIVE DISORDERS

To cite this article:

Demyanov IA, Boĭko EO, Zaĭtseva OG, Pogodina MG. The efficacy of alimemazine (solution for intramuscular injection) in complex with antidepressants in the treatment of anxiety and depressive disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(8):32‑37. (In Russ.)
https://doi.org/10.17116/jnevro201911908132

Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry)
 
МСФ на ЯМ
Close metadata
Recommended articles:
Fluvoxamine in the treatment of anxiety-depressive spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):101-109
Anxiety-depressive diso­rders in patients before and in the long terms after aortic replacement. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):83-89
Modern approaches to diagnosis and treatment of syndrome of auto­nomic dysfunction in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):66-75
The follow-up examination of children with breath-holding spells. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):76-80
Bladder dysfunction in patients with stages I—III of Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):91-99

Objective. To evaluate the efficacy of alimemazine in the form of a solution for intramuscular injections in the treatment of anxiety and depressive disorders. Material and methods. Twenty patients, who met ICD-10 criteria for anxiety and depressive disorders, participated in the clinical observation. Alimemazine was used in the form of a solution for intramuscular injection (5 mg/ml) along with SSRIs and SNRIs. Results. The significant positive dynamics in the reduction of anxiety-depressive disorders, sleep disorders and vegetative symptoms was observed in patients treated with alimemazine (solution) and antidepressants from the group of SSRIs and SSRIs. Conclusion. The drug has demonstrated efficacy and a favorable tolerability profile.

Keywords:

anxiety and depressive disorders
vegetative disorders
alimemazine
therapy effectiveness

Authors:

Demyanov I.A.

SBEI HPE KSMU of the Ministry of Healthcare of Russia, Department of Psychiatry, Krasnodar, Russia;
State Budgetary Healthcare Institution 'Specialized Clinical Psychiatric Hospital #1', Krasnodar, Russia

Boĭko E.O.

GBOU VPO "Kubanskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava Rossii, Krasnodar, 350063, Rossiĭskaia Federatsiia

Zaĭtseva O.G.

GBOU VPO "Kubanskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava Rossii, Krasnodar, 350063, Rossiĭskaia Federatsiia

Pogodina M.G.

SBEI HPE KSMU of the Ministry of Healthcare of Russia, Psychiatry Department of Post-Graduate Education, Krasnodar, Russia;
State Budgetary Healthcare Institution 'Specialized Clinical Psychiatric Hospital #1', Krasnodar, Russia

List of references:

  1. Thibaut F. Anxiety disorders: a review of current literature. Dialogues in Clinical Neuroscience. 2017;19(2):87-88.
  2. Strizhev VA. Kliniko-epidemiologicheskoe issledovanie trevozhno-depressivnykh i addiktivnykh rasstroistv u studentov-medikov: Dis... kand. med. nauk. M. 2016. (In Russ.)
  3. Mitchell AJ, Sheth B, Gill J, Yadegarfar M, Stubbs B, Yadegarfar M, Meader N. Prevalence and predictors of post-stroke mood disorders: A meta-analysis and meta-regression of depression, anxiety and adjustment disorder. General Hospital Psychiatry. 2017;47:48-60. Epub 2017 Apr 3. https://doi.org/10.1016/j.genhosppsych.2017.04.001
  4. Scholten AC, Haagsma JA, Cnossen MC, Olff M, van Beeck EF, Polinder S. Prevalence of and Risk Factors for Anxiety and Depressive Disorders after Traumatic Brain Injury: A Systematic Review. Journal of Neurotrauma. 2016;33(22):1969-1994. Epub 2016 Apr 29. https://doi.org/10.1089/neu.2015.4252
  5. Boeschoten RE, Braamse AMJ, Beekman ATF, Cuijpers P, van Oppen P, Dekker J, Uitdehaag BMJ. Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis. Journal of the Neurological Sciences. 2017;372:331-341. Epub 2016 Nov 30. https://doi.org/10.1016/j.jns.2016.11.067
  6. Chan CYY, Tsang HHL, Lau CS, Chung HY. Prevalence of depressive and anxiety disorders and validation of the Hospital Anxiety and Depression Scale as a screening tool in axial spondyloarthritis patients. International Journal of Rheumatic Diseases. 2017;20(3):317-325. Epub 2014 Oct 7. https://doi.org/10.1111/1756-185x.12456
  7. Zhang L, Fu T, Yin R, Zhang Q, Shen B. Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. BMC Psychiatry. 2017;17(1):70. https://doi.org/10.1186/s12888-017-1234-1
  8. Neznanov NG, Martynikhin IA, Mosolov SN. Diagnostika i terapiya trevozhnykh rasstroistv v Rossiiskoi Federatsii: rezul’taty oprosa vrachei-psikhiatrov. Sovremennaya Terapiya Psikhicheskikh Rasstroistv. 2017;2:2-15. (In Russ.)
  9. Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, Saxena S. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry. 2016;3:415-424. https://doi.org/10.1016/s2215-0366(16)30024-4
  10. Ibragimov DF. Alimemazin vo vrachebnoi praktike. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2008;9. (In Russ.)
  11. Ivanov SV. Aspekty farmakologicheskoi aktivnosti preparata Teralidzhen (MNN alimemazin). XV S’ezd psikhiatrov: satellitnyi simpozium kompanii «Valenta Farm». Differentsial’nyi podkhod k farmakoterapii trevozhnykh rasstroistv (reprint). Effektivnaya Farmakoterapiya. Nevrologiya i Psikhiatriya. 2011;1:9-14. (In Russ.)
  12. Kalinin VV. Teralen: primenenie v klinicheskoi praktike. Sotsial’naya i Klinicheskaya Psikhiatriya. 1993;3:(2):143-147. (In Russ.)
  13. Fernandez-Zoila A. Le Tartrate d’alimemazine en pratique en psychiatrique ambulatoire. Pratique Psychiat. 1961;22:1355-1357.
  14. Dorozhenok IYu. Kliniko-terapevticheskie aspekty psikhosomaticheskikh rasstroistv. Vrach. 2011;9:3-5. (In Russ.)
  15. Nemchin TA, Tupitsyn YuYa. Opyt lechebnogo primeneniya teralena v klinike nevrozov. Voprosy Psikhiatrii i Nevropatologii. 1965;11:218-230. (In Russ.)
  16. Shamanina VM, Zavidovskaya GI. Terapevticheskaya otsenka teralena v klinike depressivnykh sostoyanii. Zhurnal Nevropatologii i Psikhiatrii. 1964;2:1741-1745. (In Russ.)
  17. Blenfet V, Levis S, Dauby J, Beelen L. Pharmacological study of a new tranquilizing agents. Acta neurologica et Psychiatrica Belgica. 1961.
  18. Akarachkova ES. K voprosu diagnostiki i lecheniya psikhovegetativnykh rasstroistv v obshchesomaticheskoi praktike. Lechashchii Vrach. 2010;10:2-7. (In Russ.)
  19. Volovik VM, Mikhalenko IN, Nemchin TA. Neiropsikhotropnye sredstva v klinike psikhicheskikh i nervnyi zabolevanii. V kn.: Trudy leningradskogo nauchno-issledovatel’skogo psikhonevrologicheskogo instituta im. V.M. Bekhtereva. L. 1970. (In Russ.)
  20. Reshetova TV. Narusheniya vegetativnoi nervnoi sistemy v obshchei vrachebnoi praktike i ikh lechenie. Atmosfera: Nervnye Bolezni. 2008;4:6-8. (In Russ.)
  21. Krause L, Shuster S. Mechanism of action of antipruritic drug. British Medical Journal. 1983;287:1199-1200. https://doi.org/10.1136/bmj.287.6400.1199
  22. Lyubimov AV, Karcha AR. Primenenie preparata teralidzhen v terapii nadsegmentarnykh (tserebral’nykh) vegetativnykh narushenii. Nauchnye vedomosti, Ser.: Meditsina, Farmatsiya. 2012;4(123):17:20-25. (In Russ.)
  23. Mosolov SN, Kostyukova EG. Aktual’nye voprosy farmakoterapii depressii. Novye dostizheniya v terapii psikhicheskikh zabolevanii. Pod. red. Mosolova S.N. M.: BINOM; 2002. (In Russ.)
  24. Lalonde CD, Van Lieshout RJ. Treating generalized anxeiety disorder with second generation antipsychotics: a systematic review and meta-analysis. Journal of Clinical Psychopharmacology. 2011;31:326-333. https://doi.org/10.1097/jcp.0b013e31821b2b3f
  25. Pelissier H, Maserau P, Fornegran J. Psychiatric disorder and gynecological symptoms in middle aged women. Annales Médico-Psychologiques. 1962;2:346.
  26. Smulevich AA, Dorozhenok IYu, Ivanov OL, L’vov AN. Problemy psikhodermatologii: sovremennye aspekty. (In Russ.). https:/www.rlsnet.ru/articles_405.htm
  27. Michenko AV. Atopicheskii dermatit: aspekty psikhosomaticheskikh rasstroistv, ikh klassifikatsiia I kompleksnaia terapiia: Dis... kand. med. nauk. M. 2009. (In Russ.)
  28. Smulevich AB, Dorozhenok IYu, Romanov DV, L’vov AN. Psikhopatologiya psikhicheskikh rasstroistv v dermatologicheskoi klinike (model’ psikhicheskoi patologii, ogranichennoi prostranstvom kozhnogo pokrova). Psikhicheskie Rasstroistva v Obshchei Meditsine. 2012;1:4-4. (In Russ.)
  29. Lim VZ, Ho RC, Tee SI, Ho MS, Pan JY, Lim YL, Tang M., Chan K., Giam YC. Anxiety and Depression in Patients with Atopic Dermatitis in a Southeast Asian Tertiary Dermatological Centre. Annals of the Academy of Medicine, Singapore. 2016;45(10):451-455.
  30. Ladyzhenskii MYa, Gorodnichev AV, Kostyukova EG. Benzodiazepinovye anksiolitiki: vostrebovany li oni segodnya? Sovremennaya Terapiya Psikhicheskikh Rasstroistv. 2014;2:20-26. (In Russ.)
  31. Livingston MG. Benzodiazepine dependence. British Journal of Hospital Medicine. 1994;51:281-286.
  32. Nutt DJ. Death by tricyclic: the real antidepressant scandal? Journal of Clinical Psychopharmacology. 2005;19:123-124. https://doi.org/10.1177/0269881105051987
  33. Vein AM, Mosolov SN. Antikonvul’santy v psikhiatricheskoi i nevrologicheskoi praktike. SPb:. Meditsinskoe informatsionnoe agentstvo; 1994. (In Russ.)

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.